테라퓨틱스엠디 (TXMD) 주가

테라퓨틱스엠디(TXMD)는 NASDAQ에 상장된 Healthcare · Drug Manufacturers - Specialty & Generic 기업입니다. 현재가 $2.07 (-0.48%), 시가총액 $0.02B, 52주 범위 $1.04 ~ $2.77.

TherapeuticsMD, Inc. operates as a pharmaceutical royalty company in the United States and internationally. Its products portfolio includes IMVEXXY for the treatment of moderate-to-severe dyspareunia, a symptom of vulvar and vaginal atrophy due to menopause; BIJUVA to treat moderate-to-severe vasomotor symptoms due to menopause in women with a uterus; and ANNOVERA, a ring-shaped contraceptive vaginal system. The company also offers prescription prenatal vitamin products under the BocaGreenMD and vitaMedMD brand names. It has a license agreement with Mayne Pharma Group Limited. The company sells its products through wholesale distributors and retail pharmacy distributors. TherapeuticsMD, Inc.

핵심 지표

• 현재가: $2.07 (-0.48%)
• 시가총액: $0.02B
• 52주 최저~최고: $1.04 ~ $2.77
• 섹터: Healthcare
• 산업: Drug Manufacturers - Specialty & Generic
• 거래소: NASDAQ

테라퓨틱스엠디의 재무제표, 목표주가, 기관투자자(13F) 보유 현황, 관련 뉴스는 BlackQuant에서 실시간으로 확인할 수 있습니다.

테라퓨틱스엠디 재무 요약

애널리스트 전망

• 투자의견 컨센서스: 3

핵심 재무비율 · 수익성 · 성장성

• PBR (주가순자산비율): 0.87
• 순이익률: -0.19%
• 영업이익률: -1.09%

자주 묻는 질문